Sotera Health Reports Third-Quarter and Year-to-Date 2024 Results

Go back to Sotera Health Reports Third-Quarter and Year-to-Date 2024 Results

Sotera Health (SHC) PT Raised to $20 at Citi

November 5, 2024 3:41 PM EST

Citi analyst Patrick Donnelly raised the price target on Sotera Health (NASDAQ: SHC) to $20.00 (from $18.00) while maintaining a Buy rating.

The analyst comments "The moving pieces within the FY24 guide were the primary focus of the 3Q call. Management reaffirmed the FY24 top- and... More

Sotera Health Co. (SHC) Misses Q3 EPS by 1c, Beats on Revenue

November 5, 2024 7:05 AM EST

Sotera Health Co. (NASDAQ: SHC) reported Q3 EPS of $0.17, $0.01 worse than the analyst estimate of $0.18. Revenue for the quarter came in at $285 million versus the consensus estimate of $278.34 million.

For earnings history and earnings-related data on Sotera Health Co. (SHC) click here.

... More